EE200200654A - Bikalutamiidi ja tamoksifeeni farmatseutiline kombinatsioon antiandrogeense toime ja antiöstrogeense toime saavutamiseks - Google Patents

Bikalutamiidi ja tamoksifeeni farmatseutiline kombinatsioon antiandrogeense toime ja antiöstrogeense toime saavutamiseks

Info

Publication number
EE200200654A
EE200200654A EEP200200654A EEP200200654A EE200200654A EE 200200654 A EE200200654 A EE 200200654A EE P200200654 A EEP200200654 A EE P200200654A EE P200200654 A EEP200200654 A EE P200200654A EE 200200654 A EE200200654 A EE 200200654A
Authority
EE
Estonia
Prior art keywords
antiandrogenic
bicalutamide
tamoxifen
pharmaceutical combination
antiestrogenic effects
Prior art date
Application number
EEP200200654A
Other languages
English (en)
Inventor
Furr Barrington
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200654A publication Critical patent/EE200200654A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200200654A 2000-05-23 2001-05-22 Bikalutamiidi ja tamoksifeeni farmatseutiline kombinatsioon antiandrogeense toime ja antiöstrogeense toime saavutamiseks EE200200654A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0012291.1A GB0012291D0 (en) 2000-05-23 2000-05-23 Pharmaceutical combination
PCT/SE2001/001162 WO2001089515A1 (en) 2000-05-23 2001-05-22 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect

Publications (1)

Publication Number Publication Date
EE200200654A true EE200200654A (et) 2004-06-15

Family

ID=9892038

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200654A EE200200654A (et) 2000-05-23 2001-05-22 Bikalutamiidi ja tamoksifeeni farmatseutiline kombinatsioon antiandrogeense toime ja antiöstrogeense toime saavutamiseks

Country Status (23)

Country Link
US (1) US20030134899A1 (et)
EP (1) EP1292296A1 (et)
JP (1) JP2003534278A (et)
KR (1) KR20030001535A (et)
CN (1) CN1431899A (et)
AU (1) AU2001262833A1 (et)
BR (1) BR0111051A (et)
CA (1) CA2407028A1 (et)
CZ (1) CZ20023785A3 (et)
EE (1) EE200200654A (et)
GB (1) GB0012291D0 (et)
HK (1) HK1053061A1 (et)
HU (1) HUP0302276A3 (et)
IL (1) IL152545A0 (et)
IS (1) IS6589A (et)
MX (1) MXPA02011472A (et)
NO (1) NO20025638L (et)
NZ (1) NZ521979A (et)
PL (1) PL363504A1 (et)
RU (1) RU2002134483A (et)
SK (1) SK16562002A3 (et)
WO (1) WO2001089515A1 (et)
ZA (1) ZA200208845B (et)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103838D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Pharmaceutical formulation & product
US20040214898A1 (en) * 2001-11-29 2004-10-28 Steiner Mitchell S. Methods for treating hot flashes
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
US20060269611A1 (en) * 2001-11-29 2006-11-30 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
EP1666033B1 (en) * 2001-11-29 2008-12-31 GTX, Inc. Prevention and treatment of androgen-deprivation induced osteoporosis
US20080249183A1 (en) * 2001-11-29 2008-10-09 Steiner Mitchell S Treatment of androgen-deprivation induced osteoporosis
US20070197664A1 (en) * 2001-11-29 2007-08-23 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US20050080143A1 (en) * 2001-11-29 2005-04-14 Steiner Mitchell S. Treatment of androgen-deprivation induced osteoporosis
US7332525B2 (en) * 2003-01-17 2008-02-19 Castle Erik P Method of treatment of prostate cancer and composition for treatment thereof
GB0424339D0 (en) * 2004-11-03 2004-12-08 Astrazeneca Ab Combination therapy
JP2008534575A (ja) * 2005-03-29 2008-08-28 ユーエスヴィー リミテッド ビカルタミドの調製のための新規プロセス
CN114748480B (zh) * 2021-01-08 2023-10-20 轩竹生物科技股份有限公司 一种预防和/或治疗癌症的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637389A (et) * 1962-09-13
ATE28864T1 (de) * 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
CA2181358A1 (en) * 1994-01-21 1995-07-27 Nancy M. Gray Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex

Also Published As

Publication number Publication date
ZA200208845B (en) 2004-02-27
HUP0302276A2 (hu) 2003-11-28
CZ20023785A3 (cs) 2003-03-12
US20030134899A1 (en) 2003-07-17
NZ521979A (en) 2004-06-25
KR20030001535A (ko) 2003-01-06
JP2003534278A (ja) 2003-11-18
IS6589A (is) 2002-10-25
AU2001262833A1 (en) 2001-12-03
CA2407028A1 (en) 2001-11-29
PL363504A1 (en) 2004-11-29
CN1431899A (zh) 2003-07-23
SK16562002A3 (sk) 2003-05-02
EP1292296A1 (en) 2003-03-19
BR0111051A (pt) 2003-04-15
NO20025638D0 (no) 2002-11-22
WO2001089515A1 (en) 2001-11-29
GB0012291D0 (en) 2000-07-12
HUP0302276A3 (en) 2005-06-28
RU2002134483A (ru) 2004-06-27
NO20025638L (no) 2002-11-22
MXPA02011472A (es) 2004-09-06
IL152545A0 (en) 2003-05-29
HK1053061A1 (zh) 2003-10-10

Similar Documents

Publication Publication Date Title
NO20025450L (no) Ny farmasöytisk sammensetning
IS6304A (is) Kínasólínefnasambönd og lyfjafræðilegar efnasamsetningar sem innihalda þau
DE60215046D1 (de) Vernebler und anwendungsverfahren
FI991485A (fi) Uusi farmaseuttinen koostumus
CY2004011I1 (el) Aσυμμετρη συνθεση της πρεγαβαλινης
GB2385524B (en) Compositions and methods of use for extracts of magnoliaceae
AR028317A1 (es) Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion
AR028313A1 (es) Un procedimiento para la produccion de una composicion desodorante o antitranspirante
ATE324868T1 (de) Komprimierte zubereitung enthaltend nichtsteroidale entzündungshemmer
NO20005399L (no) Farmasöytisk preparat
EE200200654A (et) Bikalutamiidi ja tamoksifeeni farmatseutiline kombinatsioon antiandrogeense toime ja antiöstrogeense toime saavutamiseks
EE05020B1 (et) Glburiidi ravimkoostis
NO20004818D0 (no) Stabile doseringsformer av fluoxetin og dets enantiomere
ATE370728T1 (de) Antagonisten des gardos-kanals
HUP0302478A3 (en) Pharmaceutical solutions of modafinil compounds
NO20042502L (no) Farmasoytisk formulering omfattende bicalutamid
PT1165031E (pt) Composicao do resorcinol
EE200100281A (et) Analgeetiline ravimkoostis
EE200100084A (et) NOS inhibiitorite uued farmatseutilised kasutusvoimalused
AR028398A1 (es) Ciclipostinas, procedimiento para su preparacion, y utilizacion de las mismas
IS6857A (is) Lyfjafræðileg samsetning sem innheldur sítalópram
AR028324A1 (es) Nuevos compuestos de heterocicloalquilbenzociclobutano y heteroarilbenzociclobutano, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen
DE29812967U1 (de) Chirurgischer Clip
ITMI992023A0 (it) Procedimento per la preparazione e purificazione del tramadol
SE0100590D0 (sv) New composition and use